Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Yu

Showing results (701-710 of 774) with videos related to

Pageof 78
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 25, 2007
Hepatic venous outflow reconstruction in right lobe graft without middle hepatic veinHong Wu, Lu-Nan Yan, Bo Li, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 29, 2017
A new index predicts early allograft dysfunction following living donor liver transplantation: A propensity score analysisJiu-Lin Song, Jian Yang, Lu-Nan Yan, et al.
Natural Product Research|June 2, 2023
Identification of lignans as ATP citrate lyase (ACLY) inhibitors from the roots of <i>Pouzolzia zeylanica</i>Jin-Long Li, Jia-Yi Jiang, Shan-Shan Gu, et al.
Journal of Cellular and Molecular Medicine|April 2, 2026
Novel Prognostic and Predictive miRNA Biomarkers Shape the Landscape of T Cell Dysfunction in CancerHong-Jiu Wang, Xiao-Ling Wen, Zhe-Yu Wu, et al.
Therapeutic Advances in Medical Oncology|June 6, 2020
<i>FGFR</i> aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patientsNing Xie, Can Tian, Hui Wu, et al.
Breast (Edinburgh, Scotland)|July 24, 2025
BEBT-209, a primary CDK4 selective inhibitor, for the treatment of HR+/HER2- advanced breast cancer (BECTOP1): a phase 1, multicentre, open-label studyZhe-Yu Hu, Kegang Jiang, Can Tian, et al.
Cancer Innovation|October 28, 2024
Beyond clinical trials: CDK4/6 inhibitor efficacy predictors and nomogram model from real-world evidence in metastatic breast cancerBinliang Liu, Zhe-Yu Hu, Ning Xie, et al.
European Radiology|January 21, 2025
Prognostic and diagnostic value of [<sup>18</sup>F]FDG, <sup>11</sup>C-acetate, and [<sup>68</sup>Ga]Ga-FAPI-04 PET/CT for hepatocellular carcinomaHao Xu, Hao Wang, Shi-Zhe Yu, et al.
World Journal of Gastroenterology|March 14, 2007
Clinical study on safety of adult-to-adult living donor liver transplantation in both donors and recipientsBin Liu, Lu-Nan Yan, Wen-Tao Wang, et al.
Signal Transduction and Targeted Therapy|December 22, 2025
Oncolytic adenovirus delivery of neoantigens sensitizes low-mutation tumors to anti-PD-1 therapy and prevents metastasisKe-Yu Shen, Shi-Zhe Yu, Ying-Han Su, et al.
Pageof 78

Showing results (701-710 of 774) with videos related to

Sort By:
Pageof 78
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 25, 2007
Hepatic venous outflow reconstruction in right lobe graft without middle hepatic veinHong Wu, Lu-Nan Yan, Bo Li, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 29, 2017
A new index predicts early allograft dysfunction following living donor liver transplantation: A propensity score analysisJiu-Lin Song, Jian Yang, Lu-Nan Yan, et al.
Natural Product Research|June 2, 2023
Identification of lignans as ATP citrate lyase (ACLY) inhibitors from the roots of <i>Pouzolzia zeylanica</i>Jin-Long Li, Jia-Yi Jiang, Shan-Shan Gu, et al.
Journal of Cellular and Molecular Medicine|April 2, 2026
Novel Prognostic and Predictive miRNA Biomarkers Shape the Landscape of T Cell Dysfunction in CancerHong-Jiu Wang, Xiao-Ling Wen, Zhe-Yu Wu, et al.
Therapeutic Advances in Medical Oncology|June 6, 2020
<i>FGFR</i> aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patientsNing Xie, Can Tian, Hui Wu, et al.
Breast (Edinburgh, Scotland)|July 24, 2025
BEBT-209, a primary CDK4 selective inhibitor, for the treatment of HR+/HER2- advanced breast cancer (BECTOP1): a phase 1, multicentre, open-label studyZhe-Yu Hu, Kegang Jiang, Can Tian, et al.
Cancer Innovation|October 28, 2024
Beyond clinical trials: CDK4/6 inhibitor efficacy predictors and nomogram model from real-world evidence in metastatic breast cancerBinliang Liu, Zhe-Yu Hu, Ning Xie, et al.
European Radiology|January 21, 2025
Prognostic and diagnostic value of [<sup>18</sup>F]FDG, <sup>11</sup>C-acetate, and [<sup>68</sup>Ga]Ga-FAPI-04 PET/CT for hepatocellular carcinomaHao Xu, Hao Wang, Shi-Zhe Yu, et al.
World Journal of Gastroenterology|March 14, 2007
Clinical study on safety of adult-to-adult living donor liver transplantation in both donors and recipientsBin Liu, Lu-Nan Yan, Wen-Tao Wang, et al.
Signal Transduction and Targeted Therapy|December 22, 2025
Oncolytic adenovirus delivery of neoantigens sensitizes low-mutation tumors to anti-PD-1 therapy and prevents metastasisKe-Yu Shen, Shi-Zhe Yu, Ying-Han Su, et al.
Pageof 78